Trial Search Results
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.
Stanford is currently not accepting patients for this trial.
University of Wisconsin, Madison
Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Other: MRI
- know or suspected iron overload
- contraindication to magnetic resonance imaging
Ages Eligible for Study
10 Years - 89 Years
Genders Eligible for Study